UMass Chan Medical School and MITRE, operator of federally funded research and development centers, announced the establishment of the Health AI Assurance Laboratory, a collaborative initiative to advance health artificial intelligence in the public interest. The initiative is at the forefront of efforts in the United States, and the first in Massachusetts, to ensure AI technology in health care is safe and effective for everyone using it.

As they make their way 26.2 miles from Hopkinton to Copley Square on April 15, the UMass ALS Cellucci Fund Boston Marathon Team will be the largest group of runners in the team’s 13-year history of raising funds to support ALS research.

Five graduates from the Morningside Graduate School of Biomedical Sciences returned to campus to crown a winner for UMass Chan’s inaugural Three Minute Thesis competition. PhD student Najihah Aziz and MD/PhD student Ayush Kumar took home prizes.  

The story of Raiden Pham, an Oregon toddler with an ultra-rare genetic disease was included on the Lunaprise Museum, a digital time capsule that went to the moon with the Odysseus spacecraft in February. Tommy and Linda Pham founded Raiden Science Foundation in 2021 to raise money to support research on a treatment at UMass Chan’s Translational Institute for Molecular Therapeutics.  

Researchers have identified amino acid changes in the AGO1 protein that cause Argonaute syndrome. These genetic mutations, studied in the C. elegans model, cause an organism-wide disruption of the RNA silencing process impacting hundreds of different genes.  

UMass Chan Medical School and Lahey Hospital & Medical Center, part of the Beth Israel Lahey Health system, have signed a research affiliation agreement to create a new quantitative science research hub to improve health outcomes and disparities through population health, digital medicine and health systems science.